Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.0065 | 0.0104 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0783 | 0.2732 | 0.3362 |
Brugia malayi | MIR domain containing protein | 0.0187 | 0.0573 | 0.055 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.1006 | 0.3539 | 0.5 |
Schistosoma mansoni | stromal cell-derived factor 2 precursor-like protein | 0.0187 | 0.0573 | 0.055 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0046 | 0.0062 | 0.0099 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.034 | 0.1127 | 0.1106 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.011 | 1 |
Loa Loa (eye worm) | ryanodine receptor | 0.1042 | 0.3671 | 0.5847 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0046 | 0.0062 | 0.0038 |
Giardia lamblia | Transglutaminase/protease, putative | 0.0035 | 0.0024 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0065 | 0.0051 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.0065 | 0.0051 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0783 | 0.2732 | 0.3362 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0065 | 0.0051 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0783 | 0.2732 | 0.2714 |
Echinococcus multilocularis | expressed protein | 0.0423 | 0.143 | 0.1746 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0035 | 0.0024 | 0.5 |
Schistosoma mansoni | ryanodine receptor related | 0.2789 | 1 | 1 |
Onchocerca volvulus | 0.0187 | 0.0573 | 1 | |
Loa Loa (eye worm) | ryanodine receptor | 0.0658 | 0.2281 | 0.3634 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.011 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.0065 | 0.0051 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.1761 | 0.6278 | 0.7765 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0059 | 0.011 | 0.5 |
Echinococcus granulosus | ryanodine receptor 44f | 0.1761 | 0.6278 | 0.7765 |
Schistosoma mansoni | hypothetical protein | 0.0688 | 0.2388 | 0.237 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.2258 | 0.8077 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0059 | 0.011 | 0.0107 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0059 | 0.011 | 1 |
Echinococcus granulosus | ryanodine receptor 44f | 0.2258 | 0.8077 | 1 |
Loa Loa (eye worm) | MIR domain-containing protein | 0.0187 | 0.0573 | 0.0913 |
Trichomonas vaginalis | mannosyltransferase 1, putative | 0.0187 | 0.0573 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0684 | 0.2373 | 1 |
Echinococcus multilocularis | stromal cell derived factor 2 | 0.0187 | 0.0573 | 0.0682 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0065 | 0.0041 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0059 | 0.011 | 0.0107 |
Echinococcus granulosus | stromal cell derived factor 2 | 0.0187 | 0.0573 | 0.0682 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0035 | 0.0024 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.034 | 0.1127 | 0.1796 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0055 | 0.0088 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0065 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0509 | 0.174 | 0.2771 |
Echinococcus multilocularis | Tolloid protein 1 | 0.0046 | 0.0062 | 0.0047 |
Brugia malayi | cation channel family protein | 0.1192 | 0.4216 | 0.4202 |
Giardia lamblia | Hypothetical protein | 0.0035 | 0.0024 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.0065 | 0.0041 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.1006 | 0.3539 | 0.5 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0853 | 0.2986 | 0.2969 |
Entamoeba histolytica | MIR domain protein | 0.0187 | 0.0573 | 0.5 |
Schistosoma mansoni | ryanodine receptor 1 skeletal muscle | 0.0322 | 0.1063 | 0.1041 |
Echinococcus granulosus | Tolloid protein 1 | 0.0046 | 0.0062 | 0.0047 |
Echinococcus granulosus | expressed protein | 0.0423 | 0.143 | 0.1746 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.0065 | 0.0041 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0059 | 0.011 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.011 | 0.0086 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0059 | 0.011 | 0.0086 |
Loa Loa (eye worm) | hypothetical protein | 0.0531 | 0.1819 | 0.2898 |
Loa Loa (eye worm) | hypothetical protein | 0.1761 | 0.6278 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Drug uptake (ADMET) | = 0.03 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.03 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.04 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.04 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.06 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.06 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.09 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.09 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.09 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.09 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.1 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.1 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.12 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.12 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.14 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.14 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.22 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.22 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.29 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.29 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.33 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.33 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.34 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.34 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.48 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.48 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.93 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 0.93 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1.46 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1.46 % ID/g | Biodistribution in blood of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1.61 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 1.61 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3 % ID/g | Biodistribution in heart of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.1 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.1 % ID/g | Biodistribution in brain of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.3 % ID/g | Biodistribution in tumor of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.4 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.4 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.8 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 3.8 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 5.5 % ID/g | Biodistribution in melanoma of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 6.4 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 6.4 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 7.3 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 7.3 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 8.7 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 8.7 % ID/g | Biodistribution in kidney of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 9.7 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 9.7 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.1 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.1 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.5 % ID/g | Biodistribution in tumor of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.8 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.8 % ID/g | Biodistribution in lung of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 10.9 % ID/g | Biodistribution in melanoma of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 12.5 % ID/g | Biodistribution in melanoma of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 6 hrs | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 19.2 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 19.2 % ID/g | Biodistribution in liver of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 24.6 % ID/g | Biodistribution in eye of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 24 hrs in presence of haloperidol | ChEMBL. | 17602544 |
Drug uptake (ADMET) | = 34.8 % ID/g | Biodistribution in eye of B16F0 tumor bearing C57BL/6J mouse at 0.37-0.74 MBq, iv after 1 hr in presence of haloperidol | ChEMBL. | 17602544 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.